阿普斯特最新公布价格表

Apremilast is a drug used to treat psoriasis and psoriatic arthritis, and its price and global availability have attracted much attention. This article will discuss in detail the latest published price of Apremilast, global listing status and usage guidelines to help patients better understand this drug.

The latest announced price of Apremilast

The price varies depending on the region, specifications and purchase channels. Below is a detailed analysis of Apremire's latest announced prices.

Domestic market price

Apremilast has been launched in China and has been included in medical insurance. The winning price of medical insurance ranges from approximately US$51 to US$70. The price after reimbursement will be lower and needs to be calculated according to the specific reimbursement ratio. Through medical insurance reimbursement, the patient's out-of-pocket expenses can be significantly reduced.

International market price

In the international market, the price of Apremilast varies from country to country. Apremilast produced by Glenmark in India has 2 specifications, with different specifications and different prices. The price of a box of 30mg*30 pills is about US$22, and the price of a box of 30mg*60 pills is about US$32.

The above prices are for reference only. The price of Apremilast varies according to different regions, medical insurance policies and purchase channels. Patients should choose the appropriate drug version and purchase method according to their own circumstances.

Global availability of Apremilast

The global availability of Apremilast varies by country and region. The following is a detailed description of Apremilast's global launch.

US market

Apremilast has been approved in the US market and is widely used in the treatment of psoriasis and psoriatic arthritis. Due to its remarkable efficacy, Apremilast has a large demand in the US market.

European market

In the European market, Apremilast has also been approved and is available in many countries. Europe's medical insurance policy is relatively complete, and patients can reimburse part of their expenses through medical insurance to reduce their financial burden.

Asia Market

In the Asian market, the availability of Apremilast varies by country. In China and Japan, Apremilast has been approved and marketed, while in some other countries, Apremilast may still be in the approval process.

Understanding the global marketing status of Apremilast can help patients better understand the accessibility and scope of use of this drug.

Guidelines for Apremilast

The use of Apremilast needs to follow certain guidelines to improve the therapeutic effect and reduce adverse reactions. The following is a detailed description of the guidelines for the use of Apremilast.

Dosage

The standard dose of Apremilast is 30 mg twice daily. Patients should strictly follow the prescribed dosage under the guidance of a doctor and are not allowed to increase or decrease the dosage on their own.

Dose time

The time for taking Apremilast should be as fixed as possible. It is usually recommended to take it after breakfast and dinner. This can maintain the stability of blood drug concentration and improve the efficacy of the drug.

Precautions

While taking Apremilast, patients should undergo regular liver function tests and routine blood tests. Apremilast may have certain effects on the liver and blood system. Regular examinations can help detect and deal with potential problems in time.